GLYCOSATE VET INJECTION

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:
GLYCOPYRROLATE
Available from:
CEVA ANIMAL HEALTH PTY LTD
INN (International Name):
glycopyrrolate(0.28mg/mL)
Pharmaceutical form:
PARENTERAL LIQUID/SOLUTION/SUSPENSION
Composition:
GLYCOPYRROLATE UNGROUPED Active 0.28 mg/ml
Units in package:
50mL
Class:
VM - Veterinary Medicine
Manufactured by:
CEVA ANIMAL HEALTH
Therapeutic group:
CAT | DOG | HORSE | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH
Therapeutic area:
ANAESTHETICS/ANALGESICS
Therapeutic indications:
ANTICHOLINERGIC AGENT
Product summary:
Poison schedule: 4; Withholding period: WHP: Meat (horses): 28 days.; Host/pest details: CAT: [ANTICHOLINERGIC AGENT]; DOG: [ANTICHOLINERGIC AGENT]; HORSE: [ANTICHOLINERGIC AGENT]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [ANTICHOLINERGIC AGENT]; DOG: [ANTICHOLINERGIC AGENT]; HORSE: [ANTICHOLINERGIC AGENT]; Anticholinergic agent for horses, dogs and cats (used for treatment of non-specific diarrhoea or vomiting).
Authorization status:
Registered
Authorization number:
51271
Authorization date:
2019-07-01

Infopest verifies that this label is consistent with the

NRA Approved Text Label

READ

THE

ENCLOSED

LEAFLET

BEFORE USING THIS PRODUCT.

DIRECTIONS FOR USE:

Administer

intramuscular

intravenous injection.

Horses:

1 - 2mL/100 kg bodyweight

Dogs & Cats:

0.2mL/5kg bodyweight

MEAT

WITHHOLDING

PERIOD

(HORSES): 28 DAYS.

DISPOSE

of empty container by wrapping

with paper and putting in garbage.

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

GLYCOSATE VET

Injection

ACTIVE CONSTITUENTS:

GLYCOPYRROLATE

0.28mg/mL

Anticholinergic agent for horses, dogs

and cats

50 mL

Discarded

needles/sharps

should

immediately be placed in a designated

appropriately

labelled

‘sharps’

container.

STORE

below 25

C (Air Conditioning).

Protect from light

.

Batch No.:

Expiry Date:

NRA No.: 51271_1098

Nature Vet Pty Limited

299 Castlereagh Road

Agnes Banks NSW 2753

Tel: (02) 4578 1022

Fax: (02) 4578 2913

Product: Glycosate Vet Injection

Date; 08/06/00

Container/Carton Label

Carton has centre panel repeated on front and back

GLYCOSATE VET Injection

Creation Date: 2002

Revision Date: March 2008

Version: 2

Next revision due: Mar 2013

Material Safety Data Sheet

Glycosate Vet Injection

Page

of 4

Statement of Hazardous Nature:

Hazardous according to criteria of Worksafe Australia.

COMPANY DETAILS

Company:

Nature Vet Pty Limited

Address:

11 Moores Rd Glenorie

NSW 2157 Australia

Telephone Number:

+61 (02) 9652 7000

Emergency Telephone Number:

+61 (02) 9652 7000 (Business Hours)

Poisons Information Service: 131126

Facsimile Number:

+61 (02) 9652 7001

IDENTIFICATION

Product Name:

Glycosate Vet Injection

Other Names:

Glycosate, Glycopyrrolate

Manufacturer’s Product Code:

UN Number:

None allocated

Dangerous Goods Class and Subsidiary Risk:

None allocated

Hazchem Code:

None allocated

Poisons Schedule Number:

Schedule 4

Use:

Injectable anticholinergic agent for use in horses, dogs and cats. For animal treatment only.

GLYCOSATE VET Injection

Creation Date: 2002

Revision Date: March 2008

Version: 2

Next revision due: Mar 2013

Material Safety Data Sheet

Glycosate Vet Injection

Page

of 4

Physical Description/Properties:

Appearance:

Clear aqueous solution for injection in a labelled 50 mL amber glass vial with a rubber stopper and

aluminium cap, packaged in a labelled outer carton.

Boiling Point/Melting Point:

Not determined

Vapour Pressure:

Not determined

Specific Gravity:

Not determined

Flashpoint:

Not determined

Flammability Limits:

Not determined

Solubility in Water:

Soluble in water

Other Properties:

No other information

Ingredients:

Chemical Name

CAS Number

Proportion

Glycopyrrolate

596-51-0

0.03% (0.28 mg/mL)

Benzyl Alcohol

100-51-6

less than 10%

Ingredients determined not to be hazardous

to 100%

HEALTH HAZARD INFORMATION

Health Effects:

Acute:

Glycopyrrolate is an anticholinergic agent, and toxic effects are manifestations of the pharmacological

effect. Signs of toxicity (or allergic reaction) may include rapid, irregular heart beat, flushing, inhibition

of sweating, nausea, vomiting, dry mouth, constipation, blurred vision due to mydriasis (pupillary

dilation), headaches, nervousness, drowsiness, dizziness, insomnia and confusion.

The most likely source of toxicity is by accidental self injection.

The following toxicity data realte to the active ingredient, Glycopyrrolate.

(oral, rat): 1150 mg/kg

: (oral,-mouse) 570 mg/kg

: i(ntraperitoneal,-rat): 196 mg/kg

: (intraperitoneal,-mouse): 90 mg/kg;

GLYCOSATE VET Injection

Creation Date: 2002

Revision Date: March 2008

Version: 2

Next revision due: Mar 2013

Material Safety Data Sheet

Glycosate Vet Injection

Page

of 4

Swallowed:

Unlikely to pose a health hazard as glycopyrrolate is poorly absorbed from the gastrointestinal tract.

May cause allergic reaction in some individuals.

Eye:

Pupillary dilation leading to blurring of vision may occur. May cause transient irritation.

Skin:

May cause irritation. Possible allergic reaction.

Inhaled:

Not considered to be a likely route of exposure during normal use.

Chronic:

Possible hypersensitization is possible following long term exposure.

First Aid:

Swallowed:

No specific first aid requirements.

Eye:

If in eyes, hold eyes open and flood with water for at least 15 minutes. Protect eyes from bright light

while pupils are dilated.

Skin:

If skin contact occurs, remove contaminated clothing and wash skin thoroughly.

Inhaled:

If any symptoms occur following exposure via this route, remove person to fresh air and seek medical

attention.

First Aid Facilities:

No specific first aid facilities required.

Advice to Doctor:

To combat peripheral anticholinergic effects a quaternary ammonium anticholinesterase such as

neostigmine methylsulfate may be administered intravenously in increments of 0.25 mg in adults. That

dosage may be repeated every 5 - 10 minutes until anticholinergic activity is reversed, or up to a

maximum of 2.5 mg. Proportionally smaller doses should be used in children. Indication for repeat

doses of neostigmine should be based on close monitoring of decreases in heart rate and the return of

bowel sounds.

PRECAUTIONS FOR USE

Exposure Standards:

No standards allocated

Engineering Controls:

No engineering controls allocated

Personal Protection:

No specific protective clothing required

GLYCOSATE VET Injection

Creation Date: 2002

Revision Date: March 2008

Version: 2

Next revision due: Mar 2013

Material Safety Data Sheet

Glycosate Vet Injection

Page

of 4

Flammability:

Not considered flammable

SAFE HANDLING INFORMATION

Storage and Transport:

Store below 25

C. Protect from light.

Spills and Disposal:

Spill quantity likely to be small. Clean up spills using suitable adsorbent material. Dispose of waste in

accordance with local, state and federal laws.

Fire/Explosion Hazard:

Not considered a fire or explosion hazard.

CONTACT POINT

Nature Vet Pty Limited Technical Services Manager

(02) 9652 7000

END OF MSDS

Similar products

Search alerts related to this product

View documents history

Share this information